COVID-19

Is Novavax, the latecomer COVID vaccine, worth the wait?
Is Novavax, the latecomer COVID vaccine, worth the wait?
Medical Marketing and Media
Novavax
vaccines
COVID-19
Flag link:
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Reuters
Japan
Daiichi Sankyo
COVID-19
vaccines
Flag link:
Pfizer Stock Hits 3-Year Low—Down 50% From 2021 Peak
Pfizer Stock Hits 3-Year Low—Down 50% From 2021 Peak
Forbes
Pfizer
pharma stocks
COVID-19
Flag link:
Capturing COVID: Biopharma through the lens during the pandemic
Capturing COVID: Biopharma through the lens during the pandemic
Fierce Pharma
pharma industry
COVID-19
pandemic
Flag link:
Study suggests Covid rebound is far more common with Paxlovid than without
Study suggests Covid rebound is far more common with Paxlovid than without
Stat
Pfizer
Paxlovid
COVID-19
antivirals
Flag link:
Novavax posts higher-than-expected revenue, says prepared to further cut costs
Novavax posts higher-than-expected revenue, says prepared to further cut costs
Reuters
Novavax
earnings
vaccines
COVID-19
Flag link:
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
Motley Fool
Moderna Therapeutics
vaccines
COVID-19
Flag link:
BioNTech Stock Jumps On Surprise Profit, Sales Beat
BioNTech Stock Jumps On Surprise Profit, Sales Beat
Investors Business Daily
BioNTech
earnings
COVID-19
Flag link:
Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution
Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution
Drugs.com
Pfizer
COVID-19
Paxlovid
antivirals
Flag link:
Pfizer cuts 200 jobs at COVID drug, vaccine plant in Michigan amid $3.5B savings campaign
Pfizer cuts 200 jobs at COVID drug, vaccine plant in Michigan amid $3.5B savings campaign
Fierce Pharma
Pfizer
layoffs
COVID-19
drug manufacturing
Michigan
Flag link:
Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink
Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink
Fierce Pharma
Moderna Therapeutics
earnings
vaccines
COVID-19
Flag link:
Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say
Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say
Reuters
Moderna Therapeutics
Pfizer
COVID-19
Flag link:
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
Yahoo Finance
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Flag link:
Merck quarterly profit tops expectations on COVID pill surprise
Merck quarterly profit tops expectations on COVID pill surprise
Yahoo/Reuters
Merck
earnings
COVID-19
Flag link:
Pfizer’s new shot approval adds to a growing vaccine prowess
Pfizer’s new shot approval adds to a growing vaccine prowess
Pharma Voice
Pfizer
vaccines
meningococcal disease
COVID-19
Penbraya
Flag link:
Maternal Covid-19 vaccination offers infants immunity for up to 6 months
Maternal Covid-19 vaccination offers infants immunity for up to 6 months
Stat
COVID-19
vaccines
Pfizer
BioNTech
pregnancy
pediatric
maternal vaccines
Flag link:
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
Motley Fool
Pfizer
Moderna Therapeutics
vaccines
COVID-19
Flag link:
Pfizer Will Charge Up To $1,400 For Covid Drug Paxlovid
Pfizer Will Charge Up To $1,400 For Covid Drug Paxlovid
Forbes
Pfizer
Paxlovid
COVID-19
drug pricing
Flag link:
HHS pledges to keep Paxlovid available as it transitions to commercial market
HHS pledges to keep Paxlovid available as it transitions to commercial market
The Hill
Pfizer
Paxlovid
antivirals
COVID-19
HHS
Flag link:
Do These 5 Words From Pfizer Mean Trouble for Novavax?
Do These 5 Words From Pfizer Mean Trouble for Novavax?
Motley Fool
Pfizer
Moderna Therapeutics
Novavax
vaccines
COVID-19
Flag link:

Pages